The Genetic Metabolic Diseases Advisory Committee (GeMDAC) advises the Commissioner of Food and Drugs or designee in discharging responsibilities as they relate to helping to ensure safe and effective drugs and biologic products for human use and as required.
Similar Posts
BlendHouse Allerton LLC. Allerton, PA. 483 issued 02/20/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 02/20/2025
Short Title (70 char) BlendHouse Allerton LLC. Allerton, PA. 483 issued 02/20/2025
FEI Number 1921383
Firm Name BlendHouse Allerton LLC
Record Type 483
State PA
Establishment Type ManufacturerInstitutional Review Board (IRB) Written Procedures
Guidance for institutions and IRBs on IRB written proceduresFDA Roundup: May 31, 2024
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.Gastrointestinal Drugs Advisory Committee Roster
This page contains the Gastrointestinal roster, which lists the current members and the current number of vacancies for the committee.CDER Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality (CDER Quality Standards Program)
CDER Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality (CDER Quality Standards Program)Draft pageMedi-Fare Drug Pharmaceutical Compounding LLC. Blacksburg, SC. 483 issued 06/06/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 06/06/2025
Short Title (70 char) Medi-Fare Drug Pharmaceutical Compounding LLC. Blacksburg, SC. 483 issued 06/06/2025
FEI Number 3009925820
Firm Name Medi-Fare Drug Pharmaceutical Compounding LLC
Record Type 483